Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study.
Roy H PerlisRajesh MehtaAlison M EdwardsArun TiwariGuido W ImbensPublished in: Depression and anxiety (2018)
Pharmacogenetic testing represents a promising strategy to reduce costs and utilization among patients with mood and anxiety disorders.